In 2011, hc1 was born from our founder’s belief that every patient is unique and should be treated that way. When the high-value care movement began, healthcare organizations focused on increasing value through cutting costs, but hc1 knew that sustainable high-value care could only come through improving patient outcomes. We also determined how we could help achieve this goal: Tap into the heartbeat of healthcare—laboratory data. If labs could organize every individual’s information intelligently, they could unlock an unprecedented level of clinical decision support to personalize and improve care for all patients.
Today the hc1 High-Value Care Platform® eliminates waste and personalizes care for health systems and diagnostic laboratories nationwide by turning previously static lab data into actionable healthcare insights. Our flagship products, hc1 CRM™ and hc1 Test Utilization™, have helped us forge a broad set of laboratory and health system partnerships. Building upon this foundation, in 2018 we introduced a new era of high-value care—precision prescribing—when we invented hc1 Opioid Advisor® and hc1 PGx Advisor®, which leverage the hc1 platform to optimize medications using targeted pharmacogenetics and medication usage analysis. hc1 PGx Advisor empowers physicians to make personalized prescribing decisions supported by clinical pharmacists with access to holistic patient information, including genetics.
Using the hc1 platform, health systems can improve clinical outcomes and reduce medical spend in these ways:
As a high-value care platform, hc1 has been recognized by some of the biggest names in healthcare and technology.